United Kingdom Collective Investments

BioPharma Credit PLC (BPCR)

BioPharma Credit PLC recorded a single notable purchase by Director Graeme Proudfoot, totaling $69,160 in September 2026. This transaction represents the primary insider activity over the last ninety days. The stock currently trades near its fifty-two-week high, reflecting a 3.1% price increase during this period, following the most recent March results.
Ticker: BPCR Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for BioPharma Credit PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Graeme Proudfoot Director Executive Director
Transaction date
Purchase
Price
497.44
Quantity 64,630
Value US$1,050,008
3.5
Harry Hyman Director Executive Director
Through Anita Hyman, a closely affiliated person
Transaction date
Purchase
Price
291.16
Quantity 89,869
Value £1,459,493
Nigel Reynolds Director Executive Director
Transaction date
Purchase
Price
420.69
Quantity 47,038
Value US$1,682,915
3.5
Harry Hyman Director Executive Director
Through Anita Hyman, a closely affiliated person
Transaction date
Purchase
Price
0.72
Quantity 75
Value £54
Harry Hyman Director Executive Director
Through Anita Hyman, a closely affiliated person
Transaction date
Purchase
Price
0.70
Quantity 137
Value £96
Sapna Shah Director Executive Director
Transaction date
Purchase
Price
0.94
Quantity 42,500
Value US$39,950
Sapna Shah Director Executive Director
Transaction date
Purchase
Price
0.69
Quantity 14,448
Value £9,999
Harry Hyman Director Executive Director
Through Anita Hyman, a closely affiliated person
Transaction date
Purchase
Price
0.67
Quantity 151
Value £101
Harry Hyman Director Executive Director
Through Anita Hyman, a closely affiliated person
Transaction date
Purchase
Price
0.70
Quantity 67
Value £47
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-30 2026-09-01 B Purchase
Graeme Proudfoot

Director

Executive Director
64,630
497.44
US$1,050,008 		64,630 497.44 US$1,050,008
2026-08-03 2026-08-01 B Purchase
3.5
Harry Hyman

Director

Through Anita Hyman, a closely affiliated person Executive Director
89,869
291.16
£1,459,493 		89,869 291.16 £1,459,493
2026-08-03 2026-08-01 B Purchase
Nigel Reynolds

Director

Executive Director
47,038
420.69
US$1,682,915 		47,038 420.69 US$1,682,915
2026-06-01 2026-05-29 B Purchase
3.5
Harry Hyman

Director

Through Anita Hyman, a closely affiliated person Executive Director
75
0.72
£54 		75 0.72 £54
2026-04-16 2026-04-01 B Purchase Harry Hyman

Director

Through Anita Hyman, a closely affiliated person Executive Director
137
0.70
£96 		137 0.70 £96
2026-03-25 2026-03-01 B Purchase Sapna Shah

Director

Executive Director
42,500
0.94
US$39,950 		42,500 0.94 US$39,950
2024-12-17 2024-01-01 B Purchase Sapna Shah

Director

Executive Director
14,448
0.69
£9,999 		14,448 0.69 £9,999
2024-11-04 2024-01-01 B Purchase Harry Hyman

Director

Through Anita Hyman, a closely affiliated person Executive Director
151
0.67
£101 		151 0.67 £101
2024-05-13 2024-01-01 B Purchase Harry Hyman

Director

Through Anita Hyman, a closely affiliated person Executive Director
67
0.70
£47 		67 0.70 £47
Explore more

More insider trading research around BioPharma Credit PLC

More insider trades in United Kingdom
Similar Financials companies with insider activity
More Collective Investments companies with insider activity
More Collective Investments companies with insider activity
Insider trading in Europe